Transvenous lead extraction improved tricuspid valve function in 35.29% of patients with lead-dependent tricuspid valve dysfunction, contributing to a significant reduction in mortality.
Cohort (n=2,678)
Does transvenous lead extraction improve valve function and long-term survival in patients with lead-dependent tricuspid valve dysfunction?
Transvenous lead extraction improves tricuspid valve function in approximately one-third of patients with lead-dependent tricuspid valve dysfunction, leading to significantly better long-term survival.
BACKGROUND: Lead-related tricuspid valve dysfunction (LDTVD) has not been studied in a large population and its management remains controversial. METHODS: An analysis of the clinical data of 2678 patients undergoing transvenous lead extraction (TLE) in years 2008-2021 was conducted, with a separate group of 119 patients with LDTVD. Potential risk factors for LDTVD, improvement in valve function, and long-term prognosis after TLE were assessed. RESULTS: LDTVD was diagnosed in 4.44% of patients referred for lead extraction due to different reasons. The most common mechanism of LDTVD was propping upward or clamping down the leaflet by the lead (85.71%). The probability of LDTVD was higher in female sex, patients with valvular heart disease, atrial fibrillation, heart failure, large right ventricle and high pulmonary artery systolic pressure, the presence of only pacing lead, and in case of collision of the lead with tricuspid valve and adhesion of the lead to the heart structures. The prognosis of patients with LDTVD was worse, however, patients with improved valve function after TLE showed a significantly better long-term survival. CONCLUSIONS: Lead dependent tricuspid valve dysfunction is a potentially serious condition that requires thorough diagnostics and thoughtful management. The risk factors for LDTVD are primarily related to the course of the lead and its adhesion to the heart structures. Improvement of tricuspid valve function after TLE is observed in 35.29% of patients Patients with LDTVD have a worse long-term survival, but the improvement in valve function following TLE contributes to a significant reduction in mortality.
Polewczyk et al. (Fri,) conducted a cohort in Lead-related tricuspid valve dysfunction (n=2,678). Transvenous lead extraction (TLE) was evaluated on Improvement of tricuspid valve function after TLE. Transvenous lead extraction improved tricuspid valve function in 35.29% of patients with lead-dependent tricuspid valve dysfunction, contributing to a significant reduction in mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: